Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000942302-05-000072
Filing Date
2005-02-14
Accepted
2005-02-14 12:29:47
Documents
1

Document Format Files

Seq Description Document Type Size
1 slxp13ga1.txt SC 13G/A 12190
  Complete submission text file 0000942302-05-000072.txt   14236
Mailing Address 8540 COLONNADE CENTER DR SUITE 501 RALEIGH NC 27615
Business Address 8540 COLONNADE CENTER DR SUITE 501 RALEIGH NC 27615 9198621000
SALIX PHARMACEUTICALS LTD (Subject) CIK: 0001009356 (see all company filings)

EIN.: 943267443 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-53269 | Film No.: 05605814
SIC: 2834 Pharmaceutical Preparations

Mailing Address 388 MARKET STREET SUITE 200 SAN FRANCISCO CA 94111
Business Address 388 MARKET STREET SUITE 200 SAN FRANCISCO CA 94111 4155912700
RS INVESTMENT MANAGEMENT CO LLC (Filed by) CIK: 0001085256 (see all company filings)

EIN.: 943321067
Type: SC 13G/A